Principal Healthcare Innovators ETF company info

What does Principal Healthcare Innovators ETF do?
Principal Healthcare Innovators ETF (NASDAQ:BTEC) operates as an exchange-traded fund (ETF) focusing on the healthcare sector. It specifically targets U.S. companies at the forefront of medical innovations, including advancements in biotechnologies, pharmaceuticals, and life sciences. The ETF aims to provide investors with exposure to cutting-edge healthcare solutions, driving growth through investments in companies developing revolutionary treatments, medical devices, and technologies. Its objective is to capitalize on the rapid advancements within the healthcare industry, aiming for long-term capital appreciation by investing in companies poised for significant growth. BTEC meticulously selects companies engaged in innovative projects, from breakthrough drug discoveries to state-of-the-art healthcare services, ensuring a diversified and dynamic portfolio.
Principal Healthcare Innovators ETF company media
Company Snapshot

Is Principal Healthcare Innovators ETF a public or private company?

key
Ownership
Public

How many people does Principal Healthcare Innovators ETF employ?

people
Employees
1,847

What sector is Principal Healthcare Innovators ETF in?

pie chart
Sector
ETF

Where is the head office for Principal Healthcare Innovators ETF?

location pin
Head Office
Des Moines, United States

What year was Principal Healthcare Innovators ETF founded?

founded flag
Year Founded
2016
What does Principal Healthcare Innovators ETF specialise in?
/Investment Services /Healthcare Sector /Stock Exchange /Exchange Traded Funds /Portfolio Management /Investment Strategy

What are the products and/or services of Principal Healthcare Innovators ETF?

Overview of Principal Healthcare Innovators ETF offerings
Investment in biotechnology firms focused on groundbreaking health solutions.
Funding for advanced medical devices companies innovating patient care.
Support for digital health platforms improving healthcare accessibility and management.
Capital provision for precision medicine companies personalizing patient treatment.
Backs healthcare analytics businesses leveraging big data for better clinical outcomes.
Engagement with pharmaceutical startups developing next-generation drugs.